Navigation Links
Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions
Date:6/2/2008

olimus is a highly-potent, broad-acting compound that has demonstrated the ability to combat disease through multiple mechanisms of action including immunosuppressive, anti-angiogenic, anti-migratory, anti-proliferative, anti-fibrotic and anti-permeability activity. Based on the versatility associated with these multiple mechanisms of action, MacuSight believes that its sirolimus product may serve as a potentially highly-efficacious therapeutic for a wide range of ocular diseases and conditions, including the treatment and prevention of wet AMD and DME.

Phase 1 clinical trials in patients with wet AMD and DME have shown MacuSight's proprietary formulation of sirolimus to be safe and well-tolerated in all doses tested when delivered by either subconjunctival or intravitreal injection. Furthermore, patients who participated in these studies exhibited improvements in visual acuity that were consistent with anatomical retinal changes following a single administration of sirolimus.

About Wet Age-Related Macular Degeneration (AMD)

Age-related macular degeneration (AMD) is the leading cause of visual loss in the western world. This disease of the aging eye results in loss of the sharp, central vision that is necessary for clearly seeing objects and undertaking routine tasks including reading and driving. AMD occurs in both wet and dry forms, with the wet form accounting for the vast majority of cases of AMD-related blindness and progressing much more rapidly than dry.

About Diabetic Macular Edema

Diabetic macular edema (DME) is a serious manifestation of diabetic retinopathy that involves retinal swelling brought on by the leaking of fluid from small blood vessels within the macula. As the condition develops, central vision becomes blurred. DME can progress fairly rapidly and over just a few years can lead to permanent visual loss. There is a significant unmet need to both reverse the visual loss associated with DME and to help delay the
'/>"/>

SOURCE MacuSight, Inc.; Santen Pharmaceutical Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
2. GeneNews announces management changes to support commercialization of ColonSentry(TM)
3. AMDL Announces New GOODNAK Consumer Anti-Aging Products for Use in Skin Renewal Treatments
4. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
5. Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
6. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
7. FASgen Diagnostics, LLC Announces Production and Investment Agreement With Tetracore, Inc.
8. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
9. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
10. Favrille Announces Workforce Reduction
11. AMT Announces Presentations During the 11th Annual Meeting of the ASGT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 e2b teknologies , a ... in Northeast Ohio, today announced a leading independent multi-specialty ... its upgrade to the latest version of Sage ... practice of its kind in the region, the organization ... transactions, so efficiency and data accessibility are paramount to ...
(Date:3/5/2015)... Southlake, Texas (PRWEB) March 05, 2015 ... treatment of acute and chronic orthopedic conditions such ... runner’s knee, tennis elbow, and joint pain due ... also be administered during orthopedic surgeries to promote ... patented scientific advances in nearly pain-free bone marrow ...
(Date:3/4/2015)... , March 4, 2015 In an ... the UPMC Center for Health Security review the clinical ... can be used as bioweapons. The article, "Clinical Management ... today on the website of the New England ... Adalja, Eric Toner , and Tom Inglesby—review the ...
(Date:3/4/2015)... , March 4, 2015  Brooklyn residents now ... acute and chronic pain and injuries. Nunzio Saulle ... the grand opening of his NJS Physical Medicine and ... on Thursday, March 5, 2015. Health Plus Management, ... which is located at 1178 Flatbush Avenue. This new ...
Breaking Biology Technology:Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5Latest Clinical Information On Bioterrorism Threats 2NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2
... - Presentation to be Webcast -, MONTVALE, N.J., May ... that Noah Berkowitz, M.D., Ph.D. President,and Chief Executive Officer of ... Global Healthcare Conference on Monday, May 19, 2008,at 12:10 p.m. ... May 19-20,2008 at the Le Meridien Beach Plaza Hotel in ...
... EDISON, N.J., May 12 Informed Medical ... forums for the,bio-pharmaceutical industry, today announced the ... In this role, Stoogenke will,develop and implement ... with the objective to maintain and grow ...
... the community and its biotech ... ... ) announced today completion of the final phase of its $1 billion,effort ... ceremony at its Indianapolis operations, Lilly officials, along,with participation by Indianapolis Mayor ...
Cached Biology Technology:Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 2Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 3Informed Medical Communications Hires New Vice President of Marketing 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 3
(Date:3/2/2015)... , March 2, 2015 Synaptics ... developer of human interface solutions, today announced a ... is designed to enable rapid and secure transactions ... module for gaming is a turnkey solution providing ... ability to quickly integrate fingerprint ID solutions into ...
(Date:3/2/2015)... 2015   Neurotechnology , a provider of high-precision ... SentiGaze Software Development Kit (SDK). The SentiGaze algorithm ... off-the-shelf webcams to track eye movements and generate heatmaps ... Heatmaps can be used for applications such as analysis ... The SDK can also be used to develop interfaces ...
(Date:2/24/2015)... -- This report analyzes the worldwide markets for Iris Biometrics ... the US, Canada , Japan ... , Middle East , and ... provided for the period 2013 through 2020. Also, a seven-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... University of Malaya (UM) today announced the establishment of ... is the first Centre of its kind in improving ... in terms of their diet and disease, conducting research ... and health, providing assistance for the national cancer registry ...
... most often cultivated in the shade of large trees, can ... those parts of the landscape that are deforested and dominated ... to shop ecologically is that when coffee is grown in ... is negative. This is shown by researchers at the ...
... a kidney transplant could depend on where he or she ... University of Florida shows. The shorter the waiting time ... live. A combination of center-related factors could mean up to ... UF study is the first to analyze overall survival chances ...
Cached Biology News:Queen's University Belfast improves Malaysian public health 2Coffee cultivation good for diversity in agrarian settlements but not in forests 2Shorter wait means longer life for kidney transplant candidates 2Shorter wait means longer life for kidney transplant candidates 3
Quantibody Human Angiogenesis Array 1 (1 slide) Class: Quantitative Antibody Arrays Product Group: Antibody Array...
BD IMagnet 1 each...
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
... Casein Kinase 1, active MW: ... 150mM NaCl, 0.02% Brij-35, 1mM dithiothreitiol ... Activity data, refer to the Certificate ... enzyme. Purification: ammonium salt precipitation followed ...
Biology Products: